logo
About Contact

Moderna's Cancer Vaccine Promises Breakthroughs Amid Stock Turmoil and Global Partnerships

Technology News

Moderna's Cancer Vaccine Promises Breakthroughs Amid Stock Turmoil and Global Partnerships

Personalized mRNA vaccine lowers melanoma recurrence by 42%

NewsBytes

Personalized mRNA vaccine lowers melanoma recurrence by 42%

Moderna and Merck's personalized mRNA vaccine reduced melanoma death or recurrence by 42% in a late-stage trial, marking a significant advancement in cancer treatment.

Moderna Crashes 20% On Reportedly Leaked Cancer Vaccine Data

Investor's Business Daily

Moderna Crashes 20% On Reportedly Leaked Cancer Vaccine Data

Moderna stock crashed Thursday after a third-party leaked the purported cancer vaccine data.

Moderna stock’s 17% slump was a ‘sell the news’ event, analyst says

TheStreet

Moderna stock’s 17% slump was a ‘sell the news’ event, analyst says

Moderna (MRNA) stock plunged Thursday, Oct. 22, after Phase 3 trial results for its experimental cancer vaccine were leaked ahead of a major medical conference. Shares of Moderna fell 17.6%, while...

Moderna CEO eyes China partnerships despite geopolitical tensions

Nikkei Asia

Moderna CEO eyes China partnerships despite geopolitical tensions

HONG KONG -- Moderna, the U.S. biotech company known for developing an mRNA vaccine against COVID-19, is exploring partnerships in China as it broadens its scope, CEO Stephane Bancel told Nikkei...

Coverage dates

First reported:

First saved on ClustZ:

Coverage updated:

We use cookies to improve your experience and analyze site traffic. By clicking "Accept", you agree to our use of cookies. See our Privacy Policy.